Jacqueline Gerena | Director, Risk Management Strategy
Johnson & Johnson

Jacqueline Gerena is Director of Risk Management Strategy at Johnson & Johnson Innovative Medicine, where she leads a team dedicated to advancing Risk Evaluation and Mitigation Strategies (REMS) across multiple therapeutic areas. With more than 15 years of experience in drug safety and risk management, Jacqueline has developed and implemented innovative approaches that strengthen patient safety, improve program effectiveness, and support healthcare system collaboration. She is widely recognized for her leadership in shaping the future of safety risk management and her commitment to ensuring therapies are used safely and effectively.